DMSO-PDT of BCC - A 6 Year Follow Up

This study has been completed.
Sponsor:
Information provided by:
Norwegian University of Science and Technology
ClinicalTrials.gov Identifier:
NCT00218829
First received: September 20, 2005
Last updated: May 16, 2006
Last verified: September 2005
  Purpose

The purpose of this study is to registrate long time clinical and histological treatment response of BCC lesions treated with one or two procedures of DMSO-PDT.


Condition
Carcinoma, Basal Cell

Study Type: Observational
Study Design: Time Perspective: Longitudinal
Official Title: Dimethylsulphoxide-Supported Photodynamic Therapy of Basal Cell Carcinoma Combined With Curretage - A 6 Year Clinical and Histological Evaluation.

Further study details as provided by Norwegian University of Science and Technology:

Estimated Enrollment: 48
Study Start Date: September 1997
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • histological verified bcc.
  • one or two PDT treatments with treatment interval no longer than two weeks.
  • lesion complete response three months after therapy.

Exclusion Criteria:

  • pregnant.
  • Gorlin's syndrome.
  • morpheaform or pigmented bcc.
  • histology older than one year.
  • tumour infiltration more than four mm.
  • previous PDT treated lesions.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00218829

Sponsors and Collaborators
Norwegian University of Science and Technology
Investigators
Principal Investigator: Eidi Christensen, MD St. Olav University Hospital, Trondheim
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00218829     History of Changes
Other Study ID Numbers: EC-002
Study First Received: September 20, 2005
Last Updated: May 16, 2006
Health Authority: Norway: Norwegian Social Science Data Services

Keywords provided by Norwegian University of Science and Technology:
Photodynamic treatment
Basal cell carcinoma
DMSO

Additional relevant MeSH terms:
Carcinoma
Carcinoma, Basal Cell
Neoplasms, Glandular and Epithelial
Neoplasms by Histologic Type
Neoplasms
Neoplasms, Basal Cell

ClinicalTrials.gov processed this record on April 17, 2014